We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00886535
Recruitment Status : Active, not recruiting
First Posted : April 23, 2009
Last Update Posted : January 27, 2017
Information provided by (Responsible Party):
Leah Cream, Milton S. Hershey Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : December 2013
  Estimated Study Completion Date : July 27, 2017